Compositions and methods for treating respiratory distress
AssigneeS.I.S. Shulov Innovative Science Ltd.
InventorNaftali PRIMOR
Life of this patent
Estimating the term…
Abstract
The present invention relates to the treatment or prevention of respiratory distress using a pharmaceutical composition containing a peptide denoted ZEP3, ZEP4 or a salt thereof.
Claims21
-47. (canceled)
A method of treating or preventing respiratory distress in a subject in need thereof, the method comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a peptide selected from pGlu-Asn-Trp-Lys(Octanoyl)-OH (SEQ ID NO:
- 1), pGlu-Asn-Trp-Thr-OH (SEQ ID NO:
- 2), and pharmaceutically acceptable salts thereof.
A method of treating a subject infected with coronavirus, the method comprising the step of administering to the subject a pharmaceutical composition comprising a peptide of pGlu-Asn-Trp-Lys(Octanoyl)-OH (SEQ ID NO:
- 1), pGlu-Asn-Trp-Thr-OH (SEQ ID NO:
- 2), or a pharmaceutically acceptable salt of SEQ ID NO:
- 1 or SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.